Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. The company is headquartered in Shanghai, Shanghai and currently employs 1,446 full-time employees. The company went IPO on 2014-11-07. The firm operates three segments. The Integrated Process and Packaging Equipment & Systems segment mainly includes liquid process systems and powder-solid systems. The Consulting, Digitalization and Construction segment mainly includes design consulting, compliance service systems, as well as cleanroom and automation control systems. The Life Science Equipment and Consumables segment focuses on life science and technology consumables, advanced treatment and advanced bioprocess technologies.
AULSF stock price ended at $0.07 on 星期五, after rising 0.00%
On the latest trading day Jan 23, 2026, the stock price of AULSF rose by 0.00%, climbing from $0.07 to $0.07. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.07 and a high of $0.07. Notably, trading volume dropped by -- shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of -- shares were traded, equating to a market value of approximately $35.8M.